TY  - GEN 
AU  - Pinho, I. S.
AU  - Luz, P.
AU  - Alves, L.
AU  - Lopes-Brás, R
AU  - Patel, V.
AU  - Esperança-Martins, M.
AU  - Gonçalves, L.
AU  - Freitas, R.
AU  - Simao, D.
AU  - Galnares, M. R.
AU  - Fernandes, I.
AU  - Criado, S. A.
AU  - Casado, S. G.
AU  - Baena Cañada, José Manuel
AU  - Vega, I. M. S.
AU  - Costa, J. G.
AU  - Fernandes, A. S.
AU  - de Sousa, R. T.
AU  - Costa, L.
A4  - Medicina
PY  - 2023
SN  - 1179-1918
SN  - 1173-2563
UR  - http://hdl.handle.net/10498/31721
AB  - Background and Objectives Deescalation strategies omitting anthracyclines (AC) have been explored in early human epidermal growth factor receptor 2-positive breast cancer (HER2+ EBC), showing similar efficacy regarding pathological complete response...
LA  - eng
PB  - ADIS
TI  - Anthracyclines versus No Anthracyclines in the Neoadjuvant Strategy for HER2+ Breast Cancer: Real-World Evidence
DO  - https://doi.org/10.1007/s40261-023-01291-6
ER  -